Form 8-K - Current report:
SEC Accession No. 0001437749-24-033614
Filing Date
2024-11-06
Accepted
2024-11-06 16:08:42
Documents
16
Period of Report
2024-11-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K cont20241029_8k.htm   iXBRL 8-K 28128
2 EXHIBIT 99.1 ex_739856.htm EX-99.1 125228
7 image1.jpg GRAPHIC 3092
  Complete submission text file 0001437749-24-033614.txt   305188

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA noticker-20241106.xsd EX-101.SCH 3441
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE noticker-20241106_def.xml EX-101.DEF 11816
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE noticker-20241106_lab.xml EX-101.LAB 15848
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE noticker-20241106_pre.xml EX-101.PRE 12031
18 EXTRACTED XBRL INSTANCE DOCUMENT cont20241029_8k_htm.xml XML 2966
Mailing Address 3565 GENERAL ATOMICS COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 3565 GENERAL ATOMICS COURT, SUITE 200 SAN DIEGO CA 92121 (858) 333-5280
Contineum Therapeutics, Inc. (Filer) CIK: 0001855175 (see all company filings)

EIN.: 271467257 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42001 | Film No.: 241430966
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)